Wolfe Research Starts ResMed (RMD) at Outperform
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $222.05 -1.14%
Rating Summary:
12 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 31 | New: 13
Rating Summary:
12 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 31 | New: 13
Join SI Premium – FREE
Wolfe Research analyst Mike Polark initiates coverage on ResMed (NYSE: RMD) with a Outperform rating and a price target of $280.00.
For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.
Shares of ResMed closed at $245.71 yesterday.
You May Also Be Interested In
- Roth Capital Resumes Clene, Inc. (CLNN) at Buy, PT $10
- Kepler Cheuvreux Starts ASM International NV (ASM:NA) at Buy
- Kepler Cheuvreux Starts BE Semiconductor (BESI:NA) (BESIY) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
